Results 301 to 310 of about 1,376,217 (363)

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

open access: yesEnvironmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons   +17 more
wiley   +1 more source

State of Geographic Access to Cancer Treatment Trials in the United States: Are Studies Located Where Patients Live? [PDF]

open access: yesJCO Oncol Pract
Kirkwood MK   +7 more
europepmc   +1 more source

What business is your laboratory really in?

open access: yesForensic Science International: Synergy
M.M. Houck
doaj  

Home - About - Disclaimer - Privacy